Stewart, P., & Tomlinson, J. (2009). Selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: Is the target liver, fat, or both?
Chicago-viite (17. p.)Stewart, P., ja J. Tomlinson. Selective Inhibitors of 11beta-hydroxysteroid Dehydrogenase Type 1 for Patients with Metabolic Syndrome: Is the Target Liver, Fat, or Both? 2009.
MLA-viite (9. p.)Stewart, P., ja J. Tomlinson. Selective Inhibitors of 11beta-hydroxysteroid Dehydrogenase Type 1 for Patients with Metabolic Syndrome: Is the Target Liver, Fat, or Both? 2009.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.